IDO-IN-18
Product Specifications
UNSPSC Description
IDO-IN-18 (Compound 00815) is an IDO inhibitor. IDO-IN-18 can be used for research of immunosuppression associated infectious or cancer diseases[1].
Target Antigen
Indoleamine 2,3-Dioxygenase (IDO)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ido-in-18.html
Solubility
DMSO : 16.67 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
O=C(O)CSC1=NN=CC2=C1C=CC=C2
Molecular Weight
220.25
References & Citations
[1]Mario Mautino, et al. Preparation and disclosure of indoleamine 2,3-dioxygenase (IDO) inhibitors. Patent. WO2009073620.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-153764/IDO-IN-18-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-153764/IDO-IN-18-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
314027-92-4
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RBP3 (Retinol-binding Protein 3, Interphotoreceptor Retinoid-binding Protein, IRBP, Interstitial Retinol-binding Protein) (PE)
RBP3 (Retinol-binding Protein 3, Interphotoreceptor Retinoid-binding Protein, IRBP, Interstitial Retinol-binding Protein) (PE)
